In terms of internal rate of return (IRR), modular manufacturing facilities are less expensive than stick-built facilities, with an IRR of 11% versus 8% for stick-built facilities. This provides an excellent opportunity for business partners to optimize project costs
-- CEO, a US-based mid-sized company
Market Size
The modular pharmaceutical construction market is likely to grow from USD 2.5 billion in 2024 to reach USD 2.8 billion in 2025 and USD 7.7 billion by 2035, representing a higher CAGR of 10.7% during the forecast period from 2025 to 2035. Modular facilities, also known as prefabricated buildings, have emerged as a promising alternative to traditionally built pharmaceutical and biotechnology manufacturing plants. These innovative structures are constructed by fabricating modular units off-site in a controlled factory environment, then assembling them on-site with precision.
To learn more about this report, request a free sample copy
Market Report: Key Takeaways
Market Size & Trends
- In terms of type of modular construction, the relocatable segment holds the highest share (close to 60%) of the market.
- With regards to size of facility, the very large segment dominates the global market with close to 40% market share.
- Based on the type of industry served, the pharmaceutical segment holds the largest market share (nearly 60%) in 2025.
- In terms of type of modular construct, the hybrid skid modular constructs dominate the global market with more than 30% market share.
- With respect to type of construction component, base building segment captures the highest share in 2025.
- With regards to purpose of facility, the manufacturing facilities segment dominates the global market.
- Based on the scale of operation, the clinical operations segment holds the largest market share (nearly 55%) in 2025.
- In terms of type of product, the cell and gene therapies dominate the global market with more than 20% market share.
- With respect to type of expansion, new facilities segment captures the highest share in 2025.
- In terms of geographical regions, North America captures the majority of the market share, and Asia-Pacific is likely to grow at a faster pace in the near future.
- With regards to type of material used, the steel segment dominates the global market.
Market Overview
Modular Pharmaceutical Construction Market It is interesting to highlight that this approach has demonstrated the potential to eliminate 60% to 90% of weather-related project concerns. As a result, it presents a more efficient and reliable construction solution for the life sciences industry.
Furthermore, compared to conventional construction, modular facilities can be completed up to 40% faster, accelerating project timelines and reducing costs. This speed, coupled with enhanced reliability, has prompted pharmaceutical companies particularly those specializing in cell and gene therapies, biosimilars, and vaccines to shift toward modular manufacturing. The process involves dividing production into distinct stages, such as fermentation, purification, and formulation, enabling streamlined operations and greater flexibility.
Modular facilities also allow for smaller-scale production units, which can be rapidly deployed or scaled to meet evolving market demands. Temporary modular buildings provide additional versatility, as they can be relocated based on end-user needs. Despite these advantages, widespread adoption faces hurdles, including the complexity of mass production, stringent regulatory requirements, and significant upfront financing. Overcoming these challenges could position modular construction as a game-changer in biomanufacturing, delivering unparalleled flexibility and faster time-to-market for cutting-edge therapies.
Recent Developments
- In October 2025, Total Clean Air (UK) in collaboration with Vanguard Healthcare Solutions (UK) launched new modular pharma clean air room that will be operated as a standalone brand.
- In September 2025, Hovione (Portugal) and Microinnova Engineering (Austria) entered into the partnership to advance the development of plug and play multi-purpose modular equipment for flow chemistry.
- In June 2025, King Faisal Specialist Hospital & Research Centre (KFSHRC) partnered with Germfree to launch the first modular Advanced Therapy Medicinal Products (ATMP) manufacturing campus in Saudi Arabia.
- In January 2025, Pharmadule Morimatsu completed all 250 modules for client's new ADC facility in Singapore.
Modular Pharmaceutical Construction Market Trends
- Digital Technology Integration: The future trend will focus on the integration of digital technologies, such as digital twin technologies, and building information modeling to optimize manufacturing processes, precision and enhance facility management through real-time predictive maintenance and monitoring.
- Containerized Mobile Modules to Enhance Sustainability: The broader focus will be on containerized mobile modules to reduce site-generated waste and embodied caron. This approach will be implemented due to the ongoing focus on green-certified structures and energy-efficient models in pharmaceutical companies.
- Rising Partnerships and Collaborations Foster Progress and Innovation: Modular pharmaceutical construction service providers have forged several partnerships with other stakeholders to enhance their service portfolios. Notably, in the last few years, full facility construction agreements, service alliances and cleanroom construction agreements emerged as the most common partnership models adopted by the stakeholders engaged in this domain.
Industry Experts on Modular Pharmaceutical Construction Market
Discussions with multiple stakeholders in this domain influenced the opinions and insights presented in this study. The market report includes detailed transcripts of interviews conducted with the following individuals:
- Chief Executive Officer, Mid-sized Company, USA
- President, Small Company, USA
- President, Mid-sized Company, Canada
- Former President Life Sciences and Chemicals, Large Company, Germany
- Executive Vice President, Sales and Marketing, Mid-sized Company, USA
- Vice President Pharmaceutical and Biotechnology, Large Company, Germany
- Director of Sales, Mid-sized Company, USA
- Director of Marketing, Mid-sized Company, USA
- Former Sales Manager, Mid-sized Company, Canada
- Modular Building Manufacturing and Construction Team, Small Company, USA
Market Share Insights
Market Share by Type of Facility
- This segment highlights the distribution of market across type of facilities including relocatable and permanent.
- In 2025, the relocatable modular constructs segment holds the highest share (close to 60%) of the market.
Market Share by Size of Facility
- This segment highlights the distribution of market across various sizes of facilities, such as small, mid-sized, large and very large.
- According to our projections, in 2025, the very large companies’ segment is likely to capture majority of the modular pharmaceutical construction market share due to economies of scale, their established market presence, and available capacity for large-scale projects that are compliant to GMP / FDA standards.
- It is worth highlighting that small companies’ segment is likely to grow at a relatively higher growth rate during the forecast period driven by their agility, focus on specialized solutions like cleanrooms for emerging therapies, and ability to cater to the rising demand for scalable modular facilities in the biopharma sector.
Market Share by Type of Industry Served
- This segment highlights the distribution of market for modular pharmaceutical construction across various types of industries served, such as pharmaceutical and biotechnology.
- According to our projections, in 2025, the pharmaceutical segment (over 60%) dominates the market owing to their ability to offer faster project completion times, cost-effectiveness, flexibility, and enhanced quality control compared to traditional construction methods.
- It is worth mentioning that the biotechnology segment is likely to grow at a relatively higher growth rate during the forecast period. This is driven by the surge in demand for biologics, flexible modular facilities, technological advancements, and increased biotech investments.
Market Share by Type of Material Used
- This segment highlights the distribution of market size across different materials used for modular constructs including steel, wood and concrete.
- According to our modular pharmaceutical construction market report, in 2025, steel is the most commonly used material, capturing the largest market share (~67%).
Market Share by Type of Construction Component
- This segment highlights the distribution of modular pharmaceutical construction industry across various types of construction components, such as process equipment, base building, mechanical, electrical and plumbing system, process commodities and other construction components.
- According to our projections, in 2025, the base building segment led the global market, capturing the largest market share (~40%).
- It is worth mentioning that the process equipment segment is likely to grow at a relatively higher rate during the forecast period owing to the rising demand for specialized equipment for complex biopharmaceuticals, and advancements in automation and continuous manufacturing.
Market Share by Geographical Regions
- This segment highlights the distribution of market across various geographies, such as North America, Europe and Asia, Middle East and North Africa and rest of the world.
- According to our projections, North America is likely to capture the majority (~70%) of the modular pharmaceutical construction market share in 2025, due to its robust infrastructure, significant market presence, regulatory expertise in GMP / FDA compliance, and enhanced service offerings tailored for flexible and scalable pharmaceutical facilities.
- It is worth highlighting that the market in the rest of the world is likely to grow at a relatively higher CAGR during the forecast period.
Key Market Insights
Competitive Landscape of Modular Pharmaceutical Construction Manufacturers
The current market landscape features over 50 large, mid-sized, small and very small companies offering modular facilities and more than 250 modular cleanroom manufacturers, offering various cleanroom accessories and customization options for their applicability in the life sciences industry. These manufacturers have the required expertise to offer modular pharmaceutical construction services, across different geographical regions.
Notably, 98% of the modular pharmaceutical construction providers offer services to the pharmaceutical industry, followed by biotechnology and other industries.
Market Opportunity for Modular Pharmaceutical Construction Manufacturers
The global modular pharmaceutical construction market size is likely to be worth $ 2.8 billion in 2025 and will reach $ 7.7 billion by 2035. In terms of the type of product, cell and gene therapies segment holds the largest share of the overall market due to several factors, such as increasing clinical activity, technological advancements, and growing demand for these therapies. However, the market size for sterile products subsegment is likely to grow at a relatively higher CAGR of 10.97% during the forecast period.
The demand for modular pharmaceutical construction is driven by several factors, such as the increasing focus on workplace safety and the need for efficient construction methods, a shortage of skilled labor, growing environmental concerns, and the desire for cost-effective and sustainable building practices.
Regional Analysis: North America Holds the Largest Share
North America is Leading the Market
Companies based in North America will likely dominate the global modular pharmaceutical construction market in 2035, with majority of the players based in the region actively enhancing their service offerings. This is due to the combination of several factors, such as increased adoption of advanced technology and increasing demand for sustainable and efficient construction methods.
Asia-Pacific: An Emerging Growth Spot
The market in Asia-Pacific is likely to grow at a relatively high CAGR, during the forecast period till 2035. This is due to several factors, including increasing infrastructure investments, rising demand for green buildings, and lower construction costs compared to other regions.
Key Market Drivers
The modular pharmaceutical construction market is driven by factors, such as increased demand for flexible and efficient manufacturing facilities, sustainability concerns, and a desire for faster construction timelines.
Additionally, rising global population and urbanization are pushing for innovative solutions like modular construction, which can offer faster development and address infrastructure needs in urban areas. The increasing preference and demand for personalized therapies and novel therapeutic interventions intended for the treatment of various ailments has compelled pharmaceutical companies to look beyond the traditional manufacturing and expansion practices. Lack of adequate manufacturing infrastructure, high cost of construction and delay in project deliveries have collectively contributed to the emergence of off-site construction models.
Market Segmentation Insights
| Key Report Attributes |
Details |
| Historical Trend |
Since 2024 |
| Forecast Period |
Till 2035 |
| Market Size 2025 |
$ 2.8 Billion |
| Market Size 2035 |
$ 7.7 Billion |
| CAGR (Till 2035) |
10.7% |
| Size of Facility |
- Small
- Mid-sized
- Large
- Very Large
|
| Type of Industry Served |
- Pharmaceutical
- Biotechnology
|
| Type of Modular Construct |
- Hybrid skid Modular Constructs
- Skid-mounted Modular Constructs
- Plug-and-play Modular Constructs
- Truckable Modular Constructs
- Other Modular Constructs
|
| Type of Construction Component |
- Process Equipment
- Base Building
- Mechanical
- Electrical
- Plumbing System
- Process Commodities
- Other Construction Components
|
| Purpose of Facility |
- Manufacturing Facility
- Aseptic Filling Facility
- Research and Development Facility
- Other Facility
|
| Scale of Operation |
|
| Type of Product |
|
| Type of Expansion |
- New Facility
- Facility Expansion
- Planned Expansion
|
| Type of Modular Construction |
|
| Type of Material Used |
|
| Geographical Regions |
- North America
- Europe
- Asia
- Middle East and North Africa
- Rest of the World
|
| Analytical Insights Covered |
- Market Landscape Analysis
- Modular Cleanroom Manufacturers Analysis
- Company Competitiveness Analysis
- Partnership and Collaboration Analysis
- Case Study on Modular Projects Analysis
- Facility Construction Trends Analysis
- Market Forecast and Opportunity Analysis
|
| Strategic Insights Covered |
- Executive Infographic Summary
- Key Modular Pharmaceutical
|
| Construction Companies Profiled |
- Cytiva
- G-Con Manufacturing
- Germfree
- IPM Technologies
- KeyPlants
- ModuleCo Pharma
- NNE
- Pharmadule
(Full list of 300+ companies captured is available in the report) |
PowerPoint Presentation
(Complimentary) |
Available |
| Customization Scope |
15% Free Customization |
Frequently Asked Questions
Question 1: What is the modular construction method?
Answer: The modular construction method refers to a strategy of creating and using pre-approved, reusable content blocks (modules) to build various marketing and medical assets.
Question 2: What is the market potential for modular pharmaceutical construction?
Answer: The overall market size is likely to be USD 2.8 billion in 2025 and will be worth USD 7.7 billion in 2035.
Question 3: What is the CAGR of modular pharmaceutical construction market?
Answer: The global market for modular pharmaceutical construction is likely to grow at a CAGR of 10.7% till 2035.
Question 4: Which geographical segment is likely to capture majority share in the modular pharmaceutical construction market by 2035?
Answer: North America is likely to capture majority of the market share in the next decade.
Question 5: What are the construction materials used in the pharmaceutical industry?
Answer: The modular pharmaceutical industry utilizes various materials, including stainless steel (304 and 316 grade), aluminum, nickel, and nickel.
Question 6: Which are the top modular construction firms for pharmaceutical sector?
Answer: Cytiva, G-Con Manufacturing, Germfree, IPM Technologies, KeyPlants, ModuleCo Pharma, NNE and Pharmadule.
